Diagnostics & Research
The Diagnostics & Research industry has a total of 65 stocks, with a combined market cap of $726.2 billion, total revenue of $164.45 billion and a weighted average PE ratio of 55.35.
Market Cap
726.20B
Revenue
164.45B
Profits
13.12B
PE Ratio
55.35
Profit Margin
7.98%
Dividend Yield
0.18%
65 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | TMO | Thermo Fisher Scientific Inc. | 205.08B | -0.40% | 779,140 | 43.42B |
| 2 | DHR | Danaher Corporation | 170.94B | -0.77% | 1,407,554 | 29.57B |
| 3 | IDXX | IDEXX Laboratories, Inc. | 46.10B | -0.35% | 203,233 | 3.59B |
| 4 | IQV | IQVIA Holdings Inc. | 42.23B | -0.58% | 517,183 | 14.86B |
| 5 | A | Agilent Technologies, Inc. | 40.74B | -0.36% | 1,014,098 | 6.83B |
| 6 | MTD | Mettler-Toledo International Inc. | 26.30B | -1.00% | 71,381 | 3.91B |
| 7 | ICLR | ICON PLC | 23.30B | -0.94% | 286,230 | 8.02B |
| 8 | ILMN | Illumina, Inc. | 22.11B | -2.03% | 1,225,695 | 4.47B |
| 9 | WAT | Waters Corporation | 19.47B | -1.06% | 214,583 | 3.00B |
| 10 | LH | Laboratory Corporation of America Holdings | 19.30B | 0.10% | 326,075 | 13.54B |
| 11 | DGX | Quest Diagnostics Incorporated | 15.50B | 0.16% | 402,619 | 9.30B |
| 12 | RVTY | Revvity, Inc. | 13.49B | -1.32% | 367,722 | 2.80B |
| 13 | EXAS | Exact Sciences Corporation | 13.38B | -2.30% | 987,339 | 2.41B |
| 14 | CRL | Charles River Laboratories International, Inc. | 12.13B | -1.00% | 226,542 | 4.22B |
| 15 | QGEN | Qiagen N.V. | 9.90B | -0.32% | 425,825 | 1.96B |
| 16 | MEDP | Medpace Holdings, Inc. | 9.41B | -1.32% | 182,049 | 1.78B |
| 17 | NTRA | Natera, Inc. | 7.46B | 0.97% | 1,292,888 | 988.72M |
| 18 | SHC | Sotera Health Company | 4.76B | -1.81% | 347,706 | 990.64M |
| 19 | NEOG | Neogen Corporation | 4.35B | -1.61% | 1,174,510 | 919.09M |
| 20 | GH | Guardant Health, Inc. | 3.28B | -2.91% | 665,419 | 535.79M |
| 21 | OLK | Olink Holding AB (publ) | 3.10B | -0.16% | 944,396 | 158.93M |
| 22 | RDNT | RadNet, Inc. | 2.36B | -2.61% | 432,764 | 1.58B |
| 23 | TWST | Twist Bioscience Corporation | 2.11B | -3.46% | 979,016 | 245.11M |
| 24 | NEO | NeoGenomics, Inc. | 2.06B | -3.63% | 1,860,500 | 574.80M |
| 25 | MYGN | Myriad Genetics, Inc. | 1.57B | -2.94% | 618,962 | 734.40M |
| 26 | OPK | OPKO Health, Inc. | 1.17B | -4.43% | 2,760,757 | 866.93M |
| 27 | FLGT | Fulgent Genetics, Inc. | 856.69M | -2.99% | 180,025 | 286.41M |
| 28 | CDNA | CareDx, Inc | 649.18M | -6.69% | 911,966 | 297.14M |
| 29 | CSTL | Castle Biosciences, Inc. | 580.73M | -3.79% | 211,418 | 192.01M |
| 30 | ME | 23andMe Holding Co. | 437.66M | -1.53% | 6,068,618 | 270.18M |
| 31 | SERA | Sera Prognostics, Inc. | 187.39M | -10.48% | 243,771 | 330.00K |
| 32 | NVTA | Invitae Corporation | 179.57M | -6.34% | 10,218,682 | 481.58M |
| 33 | LAB | Standard BioTools Inc. | 176.87M | -4.74% | 826,404 | 105.17M |
| 34 | BDSX | Biodesix, Inc. | 166.48M | -3.16% | 381,419 | 44.03M |
| 35 | MDXH | MDxHealth SA | 119.13M | -1.75% | 65,877 | - |
| 36 | GTH | Genetron Holdings Limited | 112.11M | -0.54% | 12,498 | 93.36M |
| 37 | PSNL | Personalis, Inc. | 102.97M | -10.64% | 1,101,995 | 70.53M |
| 38 | NOTV | Inotiv, Inc. | 94.65M | 2.51% | 124,934 | 572.43M |
| 39 | BNR | Burning Rock Biotech Limited | 87.87M | -1.06% | 79,797 | 76.83M |
| 40 | STIM | Neuronetics, Inc. | 83.91M | 2.84% | 150,502 | 69.23M |
| 41 | ACRS | Aclaris Therapeutics, Inc. | 74.38M | -1.87% | 2,999,946 | 21.43M |
| 42 | BNGO | Bionano Genomics, Inc. | 73.41M | -8.25% | 2,496,584 | 33.61M |
| 43 | PRE | Prenetics Global Limited | 71.03M | -0.51% | 7,480 | 68.79M |
| 44 | ENZ | Enzo Biochem, Inc. | 70.18M | 0.72% | 243,802 | 20.59M |
| 45 | DMTK | DermTech, Inc. | 59.93M | -1.13% | 540,286 | 14.37M |
| 46 | VNRX | VolitionRx Limited | 56.42M | 8.64% | 169,456 | 651.04K |
| 47 | DRIO | DarioHealth Corp. | 46.81M | -3.37% | 62,861 | 23.55M |
| 48 | AWH | Aspira Women's Health Inc. | 42.17M | -0.97% | 97,877 | 9.18M |
| 49 | XGN | Exagen Inc. | 33.92M | -1.97% | 26,100 | 51.62M |
| 50 | CNTG | Centogene N.V. | 33.44M | -4.76% | 13,437 | 55.72M |
| 51 | TTOO | T2 Biosystems, Inc. | 25.42M | -15.77% | 843,707 | 11.00M |
| 52 | LMDX | LumiraDx Limited | 22.76M | 71.23% | 86,127,079 | 126.52M |
| 53 | NDRA | ENDRA Life Sciences Inc. | 17.92M | 5.47% | 99,523 | - |
| 54 | PMD | Psychemedics Corporation | 17.17M | -1.33% | 25,203 | 22.80M |
| 55 | MYNZ | Mainz Biomed B.V. | 16.97M | -2.52% | 58,041 | - |
| 56 | STRR | Star Equity Holdings, Inc. | 16.54M | 0.97% | 22,106 | 77.17M |
| 57 | TRIB | Trinity Biotech plc | 15.59M | 4.63% | 193,069 | 66.27M |
| 58 | GENE | Genetic Technologies Limited | 14.01M | -1.23% | 36,980 | 5.99M |
| 59 | BIAF | bioAffinity Technologies, Inc. | 13.55M | -10.34% | 13,670 | 321.49K |
| 60 | CHEK | Check-Cap Ltd. | 12.17M | -3.70% | 41,555 | - |
| 61 | PRPO | Precipio, Inc. | 9.23M | - | 2,875 | 13.26M |
| 62 | APDN | Applied DNA Sciences, Inc. | 8.44M | -3.62% | 65,303 | 13.37M |
| 63 | ISPC | iSpecimen Inc. | 4.54M | 6.06% | 47,337 | 10.31M |
| 64 | OPGN | OpGen, Inc. | 4.21M | -4.55% | 132,850 | 3.07M |
| 65 | INBS | Intelligent Bio Solutions Inc. | 2.95M | -2.48% | 440,748 | 2.59M |